902.Vater A., Jarosch F., Buchner K., Klussmann S. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX // Nucleic Acids Res. 2003. V.31. P.e130.
903.Vater A., Klussmann S. Toward third-generation aptamers: Spiegelmers and their therapeutic prospects // Curr. Opin. Drug Discov. Devel. 2003. V.6. P.253-261.
904.Verhelst S.H., Michiels P.J., van der Marel G.A., van Boeckel C.A., van Boom J.H. Surface plasmon resonance evaluation of various aminoglycoside-RNA hairpin interactions reveals low degree of selectivity // Chembiochem. 2004. V.5. P.937–942.
905.Vester B., Lundberg L.B., Sorensen M.D., Babu R., Douthwaite S., Wengel J. LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage // J. Am. Chem. Soc. 2002. V.124. P.13682–13683.
906.Vianini E., Palumbo M., Gatto B. In vitro selection of DNA aptamers that bind Ltyrosinamide // Bioorg. Med. Chem. 2001. V.9. P.2543-2548.
907.Vicens Q., Allen M.A., Gilbert S.D., Reznik B., Gooding A.R., Batey R.T. The Cech Symposium: A celebration of 25 years of ribozymes, 10 years of TERT, and 60 years of Tom // RNA. 2008. V.14. P.397-403.
908.Vitreschak A.G., Rodionov D.A., Mironov A.A., Gelfand M.S. Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation // Nucleic Acids Res. 2002. V.30. P.3141-3151.
909.Vo N.V., Oh J.-W., Lai M.M.C. Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates // Virology. 2003. V.307. P.301.
910.von Ahsen U., Davies J., Schroeder R. Antibiotic inhibition of group I ribozyme function // Nature. 1991. V.353. P.368-370.
911.von Ahsen U., Davies J., Schroeder R. Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics // J. Mol. Biol. 1992. V.226. P.935-941.
912.von Ahsen U., Schroeder R. Streptomycin and self-splicing // Nature. 1990. V.346. P.801.
151
913.von Ahsen U., Schroeder R. Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate // Nucleic Acids Res. 1991. V.19. P.22612265.
914.Vuyisich M., Beal P.A. Controlling protein activity with ligand-regulated RNA aptamers // Chem. Biol. 2002. V.9. P.907-913.
915.Wadkins T.S., Been M.D. Core-associated non-duplex sequences distinguishing the genomic and antigenomic self-cleaving RNAs of hepatitis delta virus // Nucleic Acids Res. 1997. V.25. P.4085–4092.
916.Wahlestedt C., Salmi P., Good L., Kela J., Johnsson T., Hokfelt T., Broberger C., Porreca F., Lai J., Ren K., Ossipov M., Koshkin A., Jakobsen N., Skouv J., Oerum H., Jacobsen M.H., Wengel J. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids // Proc. Natl. Acad. Sci. USA. 2000. V.97. P.5633–5638.
917.Wallace S.T., Schroeder R. In vitro selection and characterization of streptomycinbinding RNAs: recognition discrimination between antibiotics // RNA. 1998. V.4. P.112–123.
918.Wallimann P., Marti T., Fürer A., Diederich F. // Chem. Rev. 1997. V.97. P.1567–
1608.
919.Wallis M.G., Streicher B., Wank H., von Ahsen U., Clodi E., Wallace S.T., Famulok M., Schroeder R. In vitro selection of a viomycin-binding RNA pseudoknot // Chem. Biol. 1997. V.4. P.357-366.
920.Wallis M.G., von Ahsen U., Schroeder R., Famulok M. A Novel RNA motif for neomycin recognition // Chem. Biol. 1995. V.2. P.543–552.
921.Wang D.Y., Lai B.H., Feldman A.R., Sen D. A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes // Nucleic Acids Res. 2002. V.30. P.1735–1742.
922.Wang D.Y., Lai B.H., Sen D. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes // J. Mol. Biol. 2002. V.318. P.33–43.
923.Wang D.Y., Sen D. A novel mode of regulation of an RNA-cleaving DNAzyme by effectors that bind to both enzyme and substrate // J. Mol. Biol. 2001. V.310. P.723-734.
152
924.Wang D.Y., Sen D. Rationally designed allosteric variants of hammerhead ribozymes responsive to the HIV-1 Tat protein // Comb. Chem. High Throughput Screen. 2002. V.5. P.301–312.
925.Wang H., Tor Y. // Angew. Chem. Int. Ed. Engl. 1998. V.37. P.109.
926.Wang J., Jiang H., Liu F. In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection // RNA. 2000. V.6. P.571-583.
927.Wang K.Y., Krawczyk S.H., Bischofberger N., Swaminathan S., Bolton P.H. The tertiary structure of a DNA aptamer which binds to and inhibits thrombin determines activity // Biochemistry. 1993. V.32. P.11285-11292.
928.Wang K.Y., McCurdy S., Shea R.G., Swaminathan S., Bolton P.H. A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA // Biochemistry. 1993. V.32. P.1899-1904.
929.Wang Q.S., Unrau P.J. Ribozyme motif structure mapped using random recombination and selection // RNA. 2005. V.11. P.404-411.
930.Wang S., White K.A. Riboswitching on RNA virus replication // PNAS. 2007. V.104. P.10406-10411.
931.Wang W., Billen L.P., Li Y. Sequence diversity, metal specificity, and catalytic proficiency of metal-dependent phosphorylating DNA enzymes // Chem. Biol. 2002. V.9. P.507-517.
932.Wang Y., Killian J., Hamasaki K., Rando R.R. RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities // Biochemistry. 1996. V.35. P.12338–12346.
933.Wang Y., Rando R.R. Specific binding of aminoglycoside antibiotics to RNA // Chem. Biol. 1995. V.2. P.281–290.
934.Wang Y., Silverman S.K. Deoxyribozymes That Synthesize Branched and Lariat RNA // J. Am. Chem. Soc. 2003. V.125. P.6880-6881.
935.Wang Y., Silverman S.K. Efficient One-Step Synthesis of Biologically Related Lariat RNAs by a Deoxyribozyme // Angew. Chem. Int. Ed. 2005. V.44. P.5863-5866.
936.Warner R.G., Hundt C., Weiss S., Turnbull J.E. Identification of the heparan sulfate binding sites in the cellular prion protein // J. Biol. Chem. 2002. V.277. P.18421–18430.
153
937.Warren C.L., Kratochvil N.C.S., Hauschild K.E., Foister S., Brezinski M.L., Dervan P.B., Phillips Jr. G.N., Ansari A.Z. Defining the sequence-recognition profile of DNA-binding molecules // PNAS. 2006. V.103. P.867-872.
938.Wecker M., Smith D., Gold L. In vitro selection of a novel catalytic RNA: characterization of a sulfur alkylation reaction and interaction with a small peptide // RNA. 1996. V.2. P.982-994.
939.Wedekind J.E., McKay D.B. Crystal structure of a lead-dependent ribozyme revealing metal binding sites relevant to catalysis // Nat. Struct. Biol. 1999. V.6. P.261-268.
940.Wedekind J.E., McKay D.B. Crystal structure of the leadzyme at 1.8 Å resolution:
metal ion binding and the implications for catalytic mechanism and allo site ion
regulation // Biochemistry. 2003. V.42. P.9554-9563.
941.Weigand J.E., Sanchez M., Gunnesch E.-B., Zeiher S., Schroeder R., Suess B. Screening for engineered neomycin riboswitches that control translation initiation // RNA. 2008. V.14. P.89-97.
942.Weigand J.E., Suess B. Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast // Nucleic Acids Res. 2007.
943.Weigand B.S., Zerressen A., Schlatterer J.C., Helm M., Jäschke A. // Klussmann S., Ed. The Aptamer Handbook. Wiley-VCH, Weinheim, 2006. P.211–227.
944.Weill L., Louis D., Sargueil B. Selection and evolution of NTP-specific aptamers // Nucleic Acids Res. 2004. V.32. P.5045-5058.
945.Weinberg Z., Regulski E.E., Hammond M.C., Barrick J.E., Yao Z., Ruzzo W.L., Breaker R.R. The aptamer core of SAM-IV riboswitches mimics the ligand-binding site of SAM-I riboswitches // RNA. 2008. V.14. P.822-828.
946.Weinger J.S., Parnell K.M., Dorner S., Green R., Strobel S.A. Substrate-assisted catalysis of peptide bond formation by the ribosome // Nat. Struct. Mol. Biol. 2004. V.11. P.1101-1106.
947.Weiss S., Proske D., Neumann M., Groschup M.H., Kretzschmar H.A., Famulok M., Winnacker E.L. RNA aptamers specifically interact with the prion protein PrP // J. Virol. 1997. V.71. P.8790–8797.
154
948.Welz R., Breaker R.R. Ligand binding and gene control characteristics of tandem riboswitches in Bacillus anthracis // RNA. 2007. V.13. P.573–582.
949.Werstuck G., Green M.R. Controlling gene expression in living cells through small molecule-RNA interactions // Science. 1998. V.282. P.296–298.
950.White R., Rusconi C., Scardino E., Wolberg A., Lawson J., Hoffman M., Sullenger B. Generation of species cross-reactive aptamers using "toggle" SELEX // Mol. Ther. 2001. V.4. P.567-573.
951.White R.R., Shan S., Rusconi C.P., Shetty G., Dewhirst M.W., Kontos C.D., Sullenger B.A. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 // Proc. Natl. Acad. Sci. USA. 2003. V.100. P.5028-5033.
952.White R.R., Sullenger B.A., Rusconi C.P. Developing aptamers into therapeutics //
J.Clin. Invest. 2000. V.106. P.929–934.
953.Wiegand T.W., Janssen R.C., Eaton B.E. Selection of RNA amide synthases // Chem. Biol. 1997. V.4. P.675-683.
954.Wiegand T.W., Williams P.B., Dreskin S.C., Jouvin M.H., Kinet J.P., Tasset D. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fcε receptor I //
J.Immunol. 1996. V.157. P.221-230.
955.Williams K.P., Bartel D.P. PCR product with strands of unequal length // Nucleic Acids Res. 1995. V.23. P.4220-4221.
956.Williams K.P., Ciafre S., Tocchini-Valentini G.P. Selection of novel Mg2+- dependent self-cleaving ribozymes // EMBO J. 1995. V.14. P.4551-4557.
957.Williams K.P., Liu X.H., Schumacher T.N., Lin H.Y., Ausiello D.A., Kim P.S., Bartel D.P. Bioactive and nuclease-resistant L-DNA ligand of vasopressin // Proc. Natl. Acad. Sci. USA. 1997. V.94. P.11285-11290.
958.Willis M.C., Collins B.D., Zhang T., Green L.S., Sebesta D.P., Bell C., Kellogg E., Gill S.C., Magallanez A., Knauer S., Bendele R.A., Gill P.S., Janjic N. Liposomeanchored vascular endothelial growth factor aptamers // Bioconjug. Chem. 1998. V.9. P.573-582.
155